Parra Bravo, Celeste
Krukowski, Karen
Barker, Sarah
Wang, Chao
Li, Yaqiao
Fan, Li
Vázquez-Rosa, Edwin
Shin, Min-Kyoo
Wong, Man Ying
McCullough, Louise D.
Kitagawa, Ryan S.
Choi, H. Alex
Cacace, Angela
Sinha, Subhash C.
Pieper, Andrew A.
Rosi, Susanna
Chen, Xu
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U54NS100717)
National Institute on Aging (R01AG072758, R01AG054214, R01AG074541, R01AG074273, R01AG078185, R01AG056770, R01AG071512, R01AG066707, U01AG073323, P30AG062428, T32AG071474)
Tau Consortium (Tau Consortium)
JPB Foundation (JPB Foundation)
Rogers Family Foundation (Rogers Family Foundation)
American Heart Association (19PABH13458000)
U.S. Department of Veterans Affairs (I01BX005976)
National Institute of General Medical Sciences (RM1GM142002, R25GM130494, T32GM007250)
The Valour Foundation (The Valour Foundation)
G.R. Lincoln Family Foundation (G.R. Lincoln Family Foundation)
Louis Stokes VA Medical Center (Louis Stokes VA Medical Center)
U.S. Department of Defense (W81XWH-22-1-0129)
Article History
Received: 23 February 2024
Accepted: 15 May 2024
First Online: 24 June 2024
Declarations
:
: De-identified human plasma samples were received from the University of Texas Southwestern. Experiments were approved by Institutional Review Board (IRB) (IRB Number HSC-MS-17-0776 (Molecular and Microbiome Mechanisms after Neurological Injury), HSC-MH-17-0452 (Biorepository of Neurological Disorders Registry and Tissue Repository at UT Health) and #EM-15-35 (University Hospitals Case Medical Center, Center for Clinical Research and Technology, OH). The patient or surrogate provided written informed consent. Sex and age information are reported in Supplementary Table .
: Not applicable.
: LG is founder and equity holder of Aeton Therapeutics Inc.